The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Will Be The Estimated Market Valuation Of The High-Fidelity Long-Read Sequencing Market By The End Of 2030?
The high-fidelity long-read sequencing market has witnessed significant expansion in recent years. Its value is projected to climb from $1.53 billion in 2025 to $1.88 billion in 2026, with a compound annual growth rate (CAGR) of 22.2%. Historically, this market’s growth has been fueled by progress in sequencing chemistry accuracy, early integration into genomics research institutions, the proliferation of large-scale genome projects, a rising requirement for structural variant analysis, and enhancements in sequencing hardware performance.
The high-fidelity long-read sequencing market is anticipated to experience substantial growth over the coming years, projected to reach $4.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 22.5%. This projected expansion during the forecast period is fueled by several factors, including the increasing application of precision medicine, heightened investments in genomics-driven drug discovery, the broadening scope of rare disease research, the growing clinical integration of long-read sequencing, and improvements in sequencing cost-effectiveness. Key developments shaping this period include the increased acceptance of long-read sequencing within clinical diagnostics, a rising need for highly accurate variant detection, the expanded utilization of de novo genome assembly methods, the wider application of epigenetic and transcriptomic analysis, and the improved integration of sophisticated bioinformatics tools.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33166&type=smp
Which Major Factors Are Driving The Expansion Of The High-Fidelity Long-Read Sequencing Market?
The increasing occurrence of rare diseases is anticipated to boost the expansion of the HiFi long-read sequencing market in the future. These conditions affect a limited number of people, typically characterized by intricate symptoms and restricted treatment avenues. The rise in rare diseases stems from progress in genetic sequencing and diagnostic methods, allowing for quicker and more precise detection of conditions previously unidentified or incorrectly classified. HiFi long-read sequencing contributes to managing rare diseases by facilitating highly accurate and thorough identification of intricate genetic variations frequently overlooked by short-read sequencing, thereby resulting in swifter and more accurate diagnoses. For example, in July 2023, the Department of Health & Social Care, a government body in the UK, reported an estimated existence of over 7,000 rare diseases, with ongoing research continually uncovering new ones. About 80% of these conditions are recognized to have a genetic origin. Consequently, the growing incidence of rare diseases is fueling the expansion of the HiFi long-read sequencing market.
Which Segment Classifications Shape The High-Fidelity Long-Read Sequencing Market?
The high-fidelity long-read sequencing market covered in this report is segmented –
1) By Product Type: Instruments; Consumables; Software
2) By Sequencing Technology: Single-Molecule Real-Time Sequencing; Nanopore Sequencing; Other Sequencing Technologies
3) By Application: Clinical Diagnostics; Genomics Research; Oncology; Rare Disease Detection; Agriculture And Animal Research; Other Applications
4) By End-User: Academic And Research Institutes; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End-Users
Subsegments:
1) By Instruments: Sequencers; Library Preparation Systems; Sample Preparation Instruments; Data Collection Devices; Quality Control Instruments
2) By Consumables: Sequencing Kits; Flow Cells; Reagents; Pipette Tips; Sample Tubes
3) By Software: Data Analysis Software; Visualization Software; Sequence Alignment Software; Genome Assembly Software; Quality Assessment Software
How Are Trends Impacting The High-Fidelity Long-Read Sequencing Market?
Leading companies within the HiFi long-read sequencing market are concentrating on developing innovative solutions, such as hybrid-capture target enrichment, to improve sequencing accuracy, broaden coverage of intricate genomic regions, and accelerate the identification of structural variants for advanced research and clinical uses. Hybrid-capture target enrichment is a genomic sequencing technique that specifically isolates particular DNA or RNA regions from a sample using complementary probes, enabling focused, high-accuracy sequencing of target areas while minimizing the sequencing of irrelevant sections. For example, in July 2025, QIAGEN N.V., a Netherlands-based biotechnology company, introduced QIAseq xHYB Long Read Panels to expand its next-generation sequencing (NGS) portfolio. These panels utilize hybrid-capture enrichment to facilitate precise long-read sequencing of complex genomic regions, including repeats and structural variants, effectively overcoming the limitations of short-read technologies. They provide superior uniformity, specificity, and complete coverage for various applications, such as cancer profiling, HLA typing, and haplotype phasing, offering flexible fixed or custom formats and integrated workflows from DNA preparation to bioinformatics analysis. The advantages include streamlined efficiency and deeper insights, especially for precision medicine.
Who Are The Primary Competitors In The High-Fidelity Long-Read Sequencing Market?
Major companies operating in the high-fidelity long-read sequencing market are Azenta Inc., BGI Genomics Co. Ltd., GenScript Biotech Corporation, Novogene Co. Ltd., Takara Bio Inc., Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Inc., MGI Tech Co. Ltd., Discovery Life Sciences Inc., Eurofins Genomics LLC, CD Genomics, BaseClear B.V., Psomagen Inc., Health in Code S.L., Creative Biogene Inc., Nucleome Informatics Private Limited, Genevia Technologies Oy, JS Link Co. Ltd., SeqCenter LLC, Theragen Bio Co. Ltd.
Read the full high-fidelity long-read sequencing market report here:
https://www.thebusinessresearchcompany.com/report/high-fidelity-long-read-sequencing-market-report
Which Region Is Anticipated To See The Fastest Growth In The High-Fidelity Long-Read Sequencing Market?
North America was the largest region in the HiFi long-read sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high-fidelity long-read sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored High-Fidelity Long-Read Sequencing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=33166&type=smp
Browse Through More Reports Similar to the Global High-Fidelity Long-Read Sequencing Market 2026, By The Business Research Company
Next Generation Sequencing Market 2026
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market
Short Read Sequencing Market Report 2026
https://www.thebusinessresearchcompany.com/report/short-read-sequencing-global-market-report
Clinical Oncology Next Generation Sequencing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model